MetLife Investment Management LLC Has $3.94 Million Stock Position in Genpact Limited (NYSE:G)

MetLife Investment Management LLC raised its position in Genpact Limited (NYSE:G - Free Report) by 7.9% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 91,662 shares of the business services provider's stock after acquiring an additional 6,733 shares during the period. MetLife Investment Management LLC owned about 0.05% of Genpact worth $3,937,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Genpact by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock valued at $728,539,000 after acquiring an additional 61,376 shares during the last quarter. Victory Capital Management Inc. grew its stake in Genpact by 18.1% in the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock valued at $423,205,000 after purchasing an additional 1,511,790 shares in the last quarter. Franklin Resources Inc. increased its position in shares of Genpact by 1.3% during the 4th quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock worth $180,560,000 after purchasing an additional 55,771 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Genpact by 5.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,848,449 shares of the business services provider's stock worth $165,288,000 after purchasing an additional 208,759 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Genpact by 3.6% in the 4th quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock valued at $170,175,000 after buying an additional 133,938 shares during the last quarter. Institutional investors own 96.03% of the company's stock.

Genpact Stock Performance

Shares of NYSE:G traded down $0.64 during trading on Thursday, reaching $49.62. 260,860 shares of the stock were exchanged, compared to its average volume of 1,326,962. The firm has a market cap of $8.72 billion, a PE ratio of 17.49, a PEG ratio of 1.84 and a beta of 1.06. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76. The stock has a 50-day moving average price of $49.52 and a 200-day moving average price of $46.51.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Research analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were paid a $0.17 dividend. This is a boost from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. This represents a $0.68 annualized dividend and a yield of 1.37%. Genpact's payout ratio is 23.94%.

Insider Buying and Selling at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.80% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their target price for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. Mizuho lifted their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Finally, Needham & Company LLC boosted their price target on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Five research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $50.38.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.